Isomorphic Labs Raises $2.1B for AI Drug Discovery
LONDON, May 12, 2026 Isomorphic Labs has secured a massive $2.1 billion Series B funding round to accelerate the...
Series B funding
Advertisement
Vyriad Secures $25M to Advance In Vivo CAR-T VV169
Rochester, Minnesota | December 23, 2025 — Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies, announced the...
Digitail Raises $23M Series B to Accelerate AI-Powered Vet Clinic Platform
Toronto, Canada – November 10, 2025 — Digitail, an AI-powered practice-management software platform for veterinary clinics, announced the completion...
AAVantgarde Secures $141 Million Series B to Advance Gene Therapies for Retinal Diseases
LONDON/MILAN, Nov. 3, 2025 — AAVantgarde Bio has raised $141 million in a Series B financing round, co-led by...
Advertisement
